Financhill
Back

Aura Biosciences Quote, Financials, Valuation and Earnings

Aura Biosciences Price Quote

$10.05
-0.02 (-0.2%)
(Updated: September 16, 2024 at 3:20 PM ET)

Aura Biosciences Key Stats

Sell
14
Aura Biosciences (AURA) is a Sell

Day range:
$9.66 - $10.28
52-week range:
$5.99 - $12.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.61%

Volume:
228.8K
Avg. volume:
176.9K
1-year change:
-0.2%
Market cap:
$499.5M
Revenue:
$0
EPS:
$-1.79

How Much Does Aura Biosciences Make?

Data Unavailable

Is Aura Biosciences Growing As A Company?

Data Unavailable

Aura Biosciences Stock Price Performance

  • Did Aura Biosciences Stock Go Up Last Month?
    Aura Biosciences share price went up by 23.56% last month
  • Did AURA's Share Price Rise Over The Last Year?
    AURA share price fell by -0.2% over the past 1 year

What Is Aura Biosciences 52-Week High & Low?

Aura Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aura Biosciences?

  • How Much Debt Does Aura Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Aura Biosciences Have?
    Cash and short term investments quarterly total is $187.4M
  • What Is Aura Biosciences’s Book Value Per Share?
    Book value per share is 3.86

Is Aura Biosciences Cash Flow Positive?

  • What Is AURA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$73.4M
  • What Is Aura Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $94.9M
  • What Is Aura Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$39.3M

Aura Biosciences Return On Invested Capital

Data Unavailable

Aura Biosciences Earnings Date & Stock Price

Aura Biosciences Competitors

  • Who Are Aura Biosciences's Competitors?
    Below is a list of companies who compete with Aura Biosciences or are related in some way:
    • Fulcrum Therapeutics Inc (FULC)
    • iBio Inc (IBIO)
    • Moderna Inc (MRNA)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Aura Biosciences Dividend Yield

Aura Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 21.00
Upside from Last Price: 108.54%

Major Shareholders

  • How many AURA shares are owned by institutional investors?
    48.9M AURA shares are owned by institutional investors
  • How many AURA shares are owned by insiders?
    1.1M AURA shares are owned by insiders